ReviewFrontiers in immunology2023
Targeting RIPK1 kinase for modulating inflammation in human diseases.
Wanjin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papertrialcites it
ReviewFrontiers in immunology2023
Wanjin Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.